Cubist Systematic Strategies, LLC - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 119 filers reported holding ORAMED PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$294,735
-61.3%
24,500
-79.1%
0.00%
-50.0%
Q3 2022$761,000
+134.9%
117,477
+66.1%
0.00%
+100.0%
Q2 2022$324,000
-84.5%
70,721
-70.8%
0.00%
-88.9%
Q1 2022$2,092,000
+189.8%
241,892
+378.3%
0.02%
+157.1%
Q4 2021$722,00050,5760.01%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 290,501$2,513,0001.83%
Knoll Capital Management, LLC 20,000$173,0000.11%
Private Portfolio Partners LLC 42,250$365,4630.09%
Rossmore Private Capital 40,661$352,0000.06%
OCCUDO QUANTITATIVE STRATEGIES LP 54,233$469,0000.04%
Cubist Systematic Strategies, LLC 241,892$2,092,0000.02%
TWO SIGMA ADVISERS, LP 662,000$5,726,0000.02%
TWO SIGMA INVESTMENTS, LP 550,956$4,766,0000.01%
Jump Financial, LLC 34,800$301,0000.01%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 264,824$2,291,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders